HerHealth2026: Updates in Breast & Gynecologic Cancer Therapeutics

HerHealth2026: Updates in Breast & Gynecologic Cancer Therapeutics is a premier hybrid CME/CE conference dedicated to advancing the understanding and clinical management of cancers affecting women. Scheduled for October 9–10, 2026, in New York City, this 1.5-day conference will bring together leading oncologists, gynecologic oncologists, researchers, and multidisciplinary healthcare professionals to explore the latest developments in diagnosis, targeted therapies, biomarker-driven treatment strategies, and emerging technologies in women’s oncology. The conference will focus on key malignancies affecting women, including breast cancer, ovarian cancer, endometrial cancer, cervical cancer, and rare gynecologic cancers such as fallopian tube, vaginal, and vulvar cancers. Through expert-led sessions, panel discussions, and case-based learning, the program will address current challenges in clinical practice and highlight emerging treatment strategies that are transforming oncology care. A special focus will also be placed on precision oncology, biomarker-driven therapy selection, antibody-drug conjugates (ADCs), immune checkpoint inhibitors, and the growing role of artificial intelligence in oncology decision-making.